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Abstract
Background:  The retroviral Gag protein is the central player in the process of virion
assembly at the plasma membrane, and is sufficient to induce the formation and release of
virus-like particles. Recent evidence suggests that Gag may co-opt the host cell’s endocytic
machinery to facilitate retroviral assembly and release.
Results: A search for novel partners interacting with the Gag protein of the Moloney murine
leukemia virus (Mo-MuLV) via the yeast two-hybrid protein-protein interaction assay resulted
in the identification of endophilin 2, a component of the machinery involved in clathrin-
mediated endocytosis. We demonstrate that endophilin interacts with the matrix or MA
domain of the Gag protein of Mo-MuLV, but not of human immunodeficiency virus, HIV. Both
exogenously expressed and endogenous endophilin are incorporated into Mo-MuLV viral
particles. Titration experiments suggest that the binding sites for inclusion of endophilin into
viral particles are limited and saturable. Knock-down of endophilin with small interfering RNA
(siRNA) had no effect on virion production, but overexpression of endophilin and, to a lesser
extent, of several fragments of the protein, result in inhibition of Mo-MuLV virion production,
but not of HIV virion production.
Conclusions: This study shows that endophilins interact with Mo-MuLV Gag and affect virion
production. The findings imply that endophilin is another component of the large complex
that is hijacked by retroviruses to promote virion production. 
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The Gag protein of retroviruses plays a critical role in virion
assembly (for reviews, see [1-3]). When expressed in the
absence of all the other virus-encoded components, this
polyprotein alone is sufficient for inducing virus-like parti-
cle formation from the cell. Hence, the Gag protein has
been referred to as a “particle-making machine” [4]. The
Gag proteins of the mammalian gamma-retroviruses, such
as the Moloney murine leukemia virus (Mo-MuLV), are
translated on free ribosomes in the cytoplasm and myristy-
lated at the amino terminus before being translocated to the
plasma membrane [5]. They assemble into enveloped,
spherical structures and are then released from the cell.
During and after virion assembly, Gag precursors are
cleaved by the viral protease into four structural proteins -
termed MA, p12, CA, and NC - to form infectious virions. 
The MA domain is the major region involved in targeting
Gag to the membrane. The precursor Gag proteins are
anchored to the plasma membrane by an amino-terminal
myristate and by ionic interactions between an amino-ter-
minal cluster of basic residues in the MA domain and the
acidic plasma membrane surface [6-8]. Amino-acid substi-
tutions or deletions in the matrix protein of type 1 human
immunodeficieny virus (HIV-1) or Mo-MuLV were found to
block membrane association [9-12] or to redirect virus
assembly to cytoplasmic vacuoles (multivesicular bodies,
MVBs). These observations highlight the critical role of MA
in intracellular transport of Gag polyproteins to the site of
viral assembly. Other mutations in MA have been reported
to allow Gag proteins to reach the plasma membrane but to
result in Gag accumulation beneath the plasma membrane
[13,14]. Slightly curved, electron-dense patches were
formed, and no further capsid assembly was observed.
These studies provide evidence of involvement of the MA
domain in an early step during viral budding. 
L domains (for ‘late assembly functions’) are required for
the late stages of viral budding. These domains are located
at different regions of Gag in different retroviruses. In Mo-
MuLV, Rous sarcoma virus (RSV) and Mason-Pfizer monkey
virus (MPMV), the L domains contain a highly conserved
PPPY motif (Pro-Pro-Pro-Tyr) and are located between the
matrix and capsid domains [15-17]. In lentiviruses, the L
domains have distinct motifs - PTAPP in HIV-1 [18,19] and
YXXL (in the single-letter amino-acid code where X is any
amino acid) in equine infectious anemia virus (EIAV) [20] -
and are located at the carboxyl terminus of the Gag protein.
Despite the lack of sequence homology, many late domains
can be functionally interchanged [21-23]. 
Recent studies have revealed that a group of cellular pro-
teins of the endocytic/multivesicular pathway are involved
in the late stages of viral assembly. Tsg101, a protein
involved in vacuolar protein sorting, binds to the PTAPP
motif and is required for budding of HIV-1 and Ebola virus
[24-27]. Similarly, the WW domains of members of the
Nedd4-like family of ubiquitin protein ligases interact with
the PPPY motif and play roles in the release of viral particles
[28,29]. EIAV utilizes the YXXL motif within its Gag to
recruit AP-2, a component of the endocytic machinery, and
possibly other components such as AIP-1/ALIX, to promote
virion assembly and release [20]. 
To understand further how retroviruses such as Mo-MuLV
recruit host cellular factors to promote virion production,
we performed a two-hybrid screen of a mouse T-lymphoma
cDNA library using a murine viral Gag as ‘bait’, and identi-
fied endophilin 2 as a Gag-interacting partner. Endophilins
are involved in the formation of endocytic vesicles from the
early onset of budding until fission [30,31]. In this study,
we describe characterization of the Gag-endophilin associa-
tion and its potential role in virion production. 
Results
Identification of endophilin 2 as a Gag-interacting
protein
The yeast two-hybrid system was used to search for proteins
interacting with murine Gag. The Gag protein of the murine
AIDS (MAIDS) defective virus is responsible for its patho-
genesis, a hyperplasia and immunodeficiency disease [32].
The gag gene product of one isolate, BM5def Gag, closely
resembles Mo-MuLV Gag in the MA, capsid and NC regions
but contains a highly divergent p12 region [33]. A mouse T-
lymphoma cDNA library was screened in a two-hybrid assay
with the full-length BM5def Gag as bait to identify potential
cellular binding partners. From 150,000 yeast transformants
screened, 31 positive clones were isolated. On the basis of
sequence similarity, ten of the cDNAs encode overlapping
portions of the mouse homolog of human endophilin 2
[34] (also known as SH3P8 [35], SH3GL1 [36], and
EEN [37]). 
Endophilins are evolutionarily conserved proteins involved
in the formation of endocytic vesicles [31]. All family
members contain an amino-terminal coiled-coil domain, a
variable region and a carboxy-terminal SH3 domain.
Members of the two major subgroups in the endophilin
family, A and B, are only about 20% identical to each other.
Endophilin A associates with the cytoplasmic surface of
membranes [38], while endophilin B appears to operate at
the endoplasmic reticulum and the Golgi complex [39].
Endophilin A has three members in mammals - 1, 2 and 3 -
that are about 70% identical to each other at the amino-
acid level. 
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Gag in the yeast two-hybrid system. The full-length human
endophilin 2 was fused to the carboxyl terminus of the Gal4
activation domain (Gal4-AD), and the complete Mo-MuLV
Gag and fragments of the protein were fused to the carboxyl
terminus of LexA [40]. The yeast two-hybrid strain CTY-5d
was cotransformed with plasmids encoding Gal4AD-
endophilin 2 and the various LexA-Gag derivatives, and the
strength of interaction between the fusion proteins was
monitored by staining yeast colonies with X-gal to visualize
-galactosidase activity (Figure 1a). Gag interacted strongly
with endophilin 2. Only fusions containing full-length Gag
or the MA domain of Gag (6 and MA; see Figure 1a) inter-
acted strongly; a large fragment retaining the carboxy-termi-
nal half of MA (8) displayed a weak interaction. Other
fragments (p12, p12-CA or CA) showed no activity. No blue
color developed in yeast cells transformed with DNAs
encoding LexA-Gag derivatives plus an empty Gal4AD
vector, nor with DNAs encoding Gal4AD-endophilin 2 plus
an empty LexA vector, indicating no activation by the fusion
proteins themselves. Quantitative -galactosidase enzyme
assays of yeast cultures expressing the various constructs
were used to obtain better estimates of the strengths of the
interactions (Figure 1a). In agreement with the filter-lift
assays, constructs containing MA showed the strongest
reporter gene expression. This experiment suggests that the
major region responsible for Gag-endophilin interaction
lies within the MA domain. 
Identifying binding domains in endophilin 2 for 
Mo-MuLV Gag using the yeast two-hybrid system
To determine the region in endophilin sufficient for binding
to Mo-MuLV Gag, amino- or carboxy-terminal fragments of
endophilin 2 were fused to the activation domain in Gal4-
AD (Figure 1b) and were tested for their interactions with a
LexA-Mo-MuLV Gag fusion. Two fragments, SH3 and
V+SH3, displayed only weak interaction with Mo-MuLV
Gag. Removal of additional portions of endophilin 2
almost completely abrogated the interaction. These results
suggest that the intact endophilin, including both amino
terminus and SH3 domains, is required for the strongest
interaction with Mo-MuLV Gag. No single region could be
identified as sufficient for strong binding. Several fragments
showed weak binding, significantly above the background
level seen with controls.
Interactions between endophilin 2 and other
retroviral Gags in the yeast two-hybrid system
To evaluate whether the interaction is conserved among other
retroviruses, the interaction of endophilin 2 with multiple
Gag polyproteins, including those of RSV, HIV-1, MPMV and
simian immunodeficiency virus (SIV), were examined with
the yeast two-hybrid system [40-42]. Plasmids encoding
Gal4AD-endophilin 2 and LexA-RSV Gag were introduced
into yeast strain CTY-5d, and plasmids encoding Gal4AD-
endophilin 2 and Gal4 binding domain (Gal4BD) coupled to
Gag from HIV-1 or MPMV or SIV were introduced into yeast
strain GGY::174. The strength of the interaction between Gag
and endophilin fusions was assessed by X-gal staining of
yeast colonies for -galactosidase activity (Table 1).
Endophilin 2 interacted with RSV Gag but not any of the
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Figure 1
Mapping the binding domains in Mo-MuLV Gag and human endophilin 2
using the yeast two-hybrid system. Yeast strain CTY 10-5d was
transformed with different combinations of DNAs encoding the fusion
proteins. Fragments of Mo-MuLV Gag were fused to the DNA-binding
domain of pSH2LexA, whereas endophilin 2 was fused to the activation
domain of pGADNOT. (a) Domains in Mo-MuLV Gag assayed for
binding to endophilin 2. (b) Domains in endophilin assayed for binding
to Mo-MuLV Gag. The scoring of -galactosidase activity of yeast
colonies is as follows: -, no blue color after 24 h in reaction; +/-, blue
after 8 h; +, blue after 2 h; ++, blue between 30 min and 2 h; +++, blue in
approximately 30 min; ++++, blue between 15 and 30 min. All constructs
tested negative for self-activation. Quantitation of -galactosidase levels
was as described previously [71].
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N156other Gags tested. As previously reported, all Gags displayed
strong interactions with themselves. Endophilin 2 also inter-
acted strongly with itself in the yeast two-hybrid system,
suggesting that it was capable of dimerization. These results
indicate that there is a specific interaction between
endophilin 2 and some, but not all, retroviral Gags.
Mo-MuLV Gag interacts with another endophilin
family member
To determine whether the interaction of Mo-MuLV Gag with
endophilin 2 depended on the endophilin’s species of
origin, plasmids expressing either human or rat endophilin
2 were introduced into yeast along with Gag-expressing
plasmids. Both endophilins interacted strongly and equally
with Mo-MuLV Gag (Table 2). To test whether the Gag-
endophilin interaction is common to another member of
the endophilin family, Mo-MuLV Gag was tested for its
interaction with rat endophilin 1 in the two-hybrid system.
A plasmid encoding rat endophilin 1 fused to the carboxyl
terminus of Gal4AD was cotransformed into yeast strain
CTY10-5d with a plasmid encoding LexA Mo-MuLV Gag.
The interaction of Gag with endophilin 1 was practically as
strong as with endophilin 2 (Table 2). 
Endophilin 2 binds to Mo-MuLV Gag in vitro
To confirm and extend the results with the yeast two-hybrid
system, the binding of endophilin 2 to Mo-MuLV Gag in
vitro  was assessed by measuring the interaction of
endophilin 2 or its amino-terminal fragments, all expressed
as glutathione-S-transferase (GST) fusions, with native Gag
produced by a chronically Mo-MuLV-infected NIH 3T3 cell
line. GST or GST-endophilin fusion proteins were expressed
in bacteria, extracts were prepared, and the proteins were
resolved by 12% SDS gel electrophoresis. Coomassie Blue
staining of the gel verified that the GST fusions were
expressed (Figure 2a). Cell lysates from Mo-MuLV-infected
cells were prepared and then mixed with bacterial cell
lysates containing either GST or GST-fusion proteins; cell
lysates from naïve NIH 3T3 cells that did not express Gag
were used as a negative control. Glutathione-Sepharose
beads were added to the lysate mixture, and the beads were
subsequently washed with binding buffer and resuspended
in SDS sample buffer. 
Proteins eluted from beads were analyzed by western blot-
ting with an anti-capsid antibody. We found that Mo-MuLV
Gag was captured only by GST-endophilin-2 beads, but not
by GST, GST-N125, or GST-SH3 beads (Figure 2b;
compare lane 5 with lanes 2, 3 and 4). Reprobing the same
blot with anti-GST antiserum showed that all the GST
fusion proteins were successfully bound to the beads and
recovered, and so were available for the interaction (data
not shown). Gag was detected only in Mo-MuLV-infected
NIH 3T3 cell lysates, and not in uninfected NIH 3T3 cell
lysates (Figure 2b; lane 5 versus lane 9), indicating that the
Gag antiserum did not cross-react with the GST fusion pro-
teins themselves or with any other proteins on the beads.
Although the levels of bound Gag proteins were low,
binding to full-length endophilin was readily detectable in
repeated experiments. Binding of Gag to any of the frag-
ments was too low for detection. These results demonstrate
that endophilin 2 and Mo-MuLV Gag can interact in vitro.
Exogenously expressed endophilin 2 associates with
Mo-MuLV virion particles
To monitor the interaction between endophilin and Mo-
MuLV Gag in vivo, we investigated whether exogenously
expressed endophilin 2 could be incorporated into virion
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Table 1
Interactions between endophilin 2 and retroviral Gag proteins
in the yeast two-hybrid system
pGADNOT-AD fusion
pSH2-LexA fusion Endophilin 2 Gag
Mo-MuLV Pr65 Gag +++ ++++
RSV Pr65 Gag ++/+ ++++
MPMV Pr76 Gag - ++
SIV Pr57 Gag - +++
HIV-1 Pr55 Gag - ++++
Human endophilin 2 ++++
The various Gag proteins were fused to the DNA-binding domain, and
human endophilin 2 was fused to the activation domain. All constructs
tested negative for self-activation. Symbols: -, no blue color after 24 h in
reaction; +, yeast turn blue after 2 h; ++, blue develops between 30 min
and 2 h; +++, blue in approximately 30 min; ++++, blue between 15
and 30 min.
Table 2
Mo-MuLV Gag interacts with another endophilin family
member in the yeast two-hybrid system
pSH2-LexA fusion
pGADNOT-AD fusion Mo-MuLV Gag pSH2-1
Rat endophilin 1 +++ -
Rat endophilin 2 +++ -
Human endophilin 2 +++ -
pGADNOT - -
Symbols: -, no blue color after 24 h in reaction; +++, yeast turn blue in
approximately 30 min.particles. We transfected 293T cells with an expression vector
encoding amino-terminal HA-epitope-tagged endophilin 2,
either alone or together with a wild-type Mo-MuLV proviral
DNA. The culture medium was harvested 48 h post-transfec-
tion and virions were purified by sedimentation through
25/45% sucrose step gradients. Virions were collected from
the interface of the sucrose gradient, and virion proteins in
pellets were solubilized in SDS sample buffer, resolved by gel
electrophoresis and analyzed by western blotting. Plasmid
DNA encoding an irrelevant HA-tagged protein, annexin II
light chain (HA-p11), was used as a negative control.
Plasmid DNA encoding an HA-tagged fragment of nucleolin
(HA-nuc212), known to be efficiently incorporated into
virion particles, served as a positive control [43]. 
Both the precursor Pr65 Gag in the cell lysate and capsid in
virions were detected after transfection of a proviral DNA
(Figure 3a,c; lanes 2, 4, 6 and 8). HA-endophilin 2 was
clearly detected in particles purified from cells expressing
viral proteins (Figure 3d; lane 8), but not from cells in which
no Gag was expressed (Figure 3d; lane 7). As anticipated, we
observed no HA-p11 in particles (Figure 3d; lane 4 versus
lane 3), while substantial levels of HA-nuc212 were recov-
ered in virions (Figure 3d; lane 6 versus lane 5). This experi-
ment suggests that HA-tagged endophilin 2 can specifically
associate with Mo-MuLV virion particles. 
To obtain an estimate of the proportion of intracellular
endophilin 2 that is incorporated into virions, serial dilu-
tions of cell lysates were prepared and compared with virion
lysates by analysis on the same western blots. These experi-
ments suggest that virions in the culture medium contain
approximately 0.1-0.2% of the HA-endophilin 2 present
intracellularly (Figure 3e). This fraction is as much as 100
times lower than the corresponding fraction of a positive
control protein, HA-Nuc212, which is very efficiently incor-
porated into virions. While low, the fraction for endophilin 2
is at least 10 times higher than that for the negative control
protein (Figure 3f; less than 0.01%).
To further verify the association of endophilin 2 with virion
particles, the preparations were analyzed on linear sucrose
gradients. Culture medium was harvested from cells
cotransfected with a plasmid encoding HA-endophilin 2
and a proviral DNA, and virions were purified on a 25/45%
sucrose step gradient as before. The purified virions were
then applied to a 20-60% linear sucrose gradient
(Figure 4a). Fractions were collected, and proteins were pre-
cipitated by trichloroacetic acid (TCA) and analyzed by
western blotting with anti-capsid antibody and anti-HA
antibody (Figure 4b,c). A major peak of HA-endophilin,
migrating as a doublet of proteins at the expected molecular
weight, was detected at a density of about 1.12 g/ml, and
comigrating with capsid in fractions 9, 10, and 11. We do
not know the origin of the doublet of proteins, though the
faster-migrating one of the pair of bands comigrates with
the single species detected in the cell (data not shown). A
smaller amount of endophilin was also recovered at the top
of the gradient (fractions 16 and 17) along with the bulk
membrane fraction and low molecular weight proteins that
do not enter the gradient. Taken together, these results show
that endophilin 2 and Gag associate in vivo and copurify in
virion particles.
Exogenously expressed endophilin 2 is protected
from proteases within Mo-MuLV virion particles 
Endophilin 2 could associate with virion particles simply
as a contaminant in copurifying microvesicles, or through
http://jbiol.com/content/3/1/4 Journal of Biology 2003, Volume 3, Issue 1, Article 4 Wang et al.  4.5
Journal of Biology 2003, 3:4
Figure 2
Endophilin 2 binds to Mo-MuLV Gag in vitro. (a) Bacterial lysates
expressing either GST, GST-N125 or GST-SH3 fragments of
endophilin or GST-endophilin 2 (full-length; ‘enph 2’ on this and
subsequent figures) were resolved by electrophoresis on 12% SDS gels,
and the gel was stained with Coomassie Brilliant Blue. (b) Bacterial
lysates expressing GST fusions were mixed with mammalian cell lysates
either from Mo-MuLV chronically infected NIH 3T3 or from naïve NIH
3T3 cells. Proteins in the cell lysates that bound to GST fusion proteins
were recovered with glutathione-Sepharose beads. Beads were then
boiled in SDS sample buffer and the proteins were resolved by
electrophoresis on 12% gels and analyzed by western blotting with an
anti-capsid antibody.
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Mr (kDa)an association with the outer surface of the budding
virions. Nonspecifically associated proteins are sensitive to
digestion by subtilisin, while proteins in the virion parti-
cles are protected from digestion by the virion envelope
[44]. To test whether the copurified endophilin is present
inside the viral particles, virion particles purified from
culture medium by step gradient were subjected to diges-
tion with increasing amounts of subtilisin. Digested
virions were then repurified through a 25% sucrose
cushion and their protein components were analyzed by
western blotting (Figure 5a). Although envelope proteins
on the virion surface were degraded by treatment of the
virions with low levels of protease, the capsid and HA-
endophilin proteins were protected even at very high con-
centration of protease. Permeabilization of virion particles
with 0.2% NP-40 abolished the protection of capsid and
endophilin, and these proteins were then degraded even at
low concentration of protease (Figure 5b). This experiment
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Figure 3
Incorporation of HA-endophilin 2 into Mo-MuLV virions. The 293T cells were transiently transfected with 2 g of plasmid encoding HA-tagged
endophilin 2, either alone or together with 10 g of proviral DNA, as indicated. The proteins in cell lysates and purified virions were analyzed by
western blotting with (a,c) anti-capsid and (b,d) anti-HA antibodies. Cells were transfected with plasmids expressing (e) HA-p11 (annexin II light
chain) or (f) HA-endophilin 2 along with Mo-MuLV DNA, and serial dilutions of cell lysates and virion proteins were analyzed by western blot with
anti-HA antisera.
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inside the virions. 
The incorporation of exogenously expressed
endophilin 2 is saturable
To characterize the association further, we examined the
level of incorporation of endophilins into virions with
increasing levels of expression in the producer cells. The
293T cells were transfected with increasing amounts of
plasmid DNA encoding HA-endophilin in the presence of a
constant level of proviral DNA. The culture medium was
harvested and purified on a 25%/45% step gradient, and
proteins in the virion particles and in cell lysates were ana-
lyzed by western blotting with an anti-HA and an anti-
capsid antibody. The levels of incorporated endophilin 2
inside the virions quickly reached a plateau, and no higher
levels were found even with dramatically increasing
amounts of endophilin 2 expressed inside the cells
(Figure 6). This experiment suggests that the binding sites
for endophilin inside the virions are limited and saturable.
Furthermore, it is unlikely that the recovery of endophilin 2
in the virion particles can be attributed to nonspecific cont-
amination by retention of cellular membrane components. 
Incorporation of endogenous endophilin 2 and other
endocytic proteins into Mo-MuLV virion particles
To investigate whether endogenous endophilin 2 is incor-
porated into virion particles, 293T cells were either mock-
transfected or transfected with a Mo-MuLV proviral DNA.
Culture supernatants were collected and virions were
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Figure 4
Copurification of HA-endophilin 2 with virions. The 293T cells were cotransfected with 2 g of plasmid encoding HA-endophilin 2 and 10 g of
proviral DNA. Virion particles purified through a 25/45% sucrose gradient were reloaded on a 20-60% linear sucrose gradient, and 20 fractions were
collected. (a) A plot of the gradient density. (b,c) Proteins in these fractions were precipitated with TCA and analyzed by western blotting with (b)
anti-HA and (c) anti-capsid antibodies. The virions migrate near the middle of the gradient and are marked by the comigration of CA and a doublet
of endophilin proteins (fractions 9-11). A small amount of endophilin is also found at the top of the gradient (fractions 16-19). The bulk of the
membrane-associated and low molecular weight proteins remains at the top of the gradient; the huge amount of protein in these fractions cause
distortions in the mobility of the proteins in these lanes. High-molecular-weight proteins at the top of the gradient are also recognized by weak
nonspecific reactivity in the anti-HA antibody.
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CApurified through 25%/45% sucrose layers. Proteins in the
virions were analyzed by western blotting with antibodies
specific for various endocytic proteins. Endogenous
endophilin 2 was incorporated at significant levels into the
virions only from cells expressing Gag, but not when Gag
was absent (Figure 7a). Comparison of the levels in the
intracellular lysates with the virion lysates on these blots
suggests that about 0.7% of the endogenous endophilin 2 is
recovered in the virus. Other endocytic components that
were substantially detected in the virion particles were a
subunit of the AP-2 adaptor complex (-adaptin; about 0.1-
0.2% of intracellular levels) and clathrin (about 2% of intra-
cellular levels; Figure 7b,c). In contrast, dynamin 2, the
major endocytic partner of endophilin, was not detectably
incorporated (Figure 7d). Without calibration with stan-
dards, it is difficult to estimate the amounts of these mole-
cules per virion. Nevertheless, these results suggest that not
every endocytic protein is significantly incorporated
into virion particles, and that endophilin is not acciden-
tally  incorporated just because of its proximity to the
plasma membrane. 
Two of these virion-associated proteins were tested for their
resistance to protease digestion by subtilisin, as was done
previously for exogenously expressed HA-endophilin. Both
-adaptin and clathrin present in the virion preparations
were fully protected from proteolysis, under conditions in
which the external viral Env protein was fully degraded
(Figure 7e,f). Thus, these proteins are not simply bound to
the outside of the virions, nor released from cells in associa-
tion with the microvesicles that are known to contaminate
virion preparations [44].
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Figure 5
HA-endophilin 2 is incorporated inside Mo-MuLV virions. Equal
amounts of purified virion particles were subjected to subtilisin
digestion at 0, 1, 10 or 100 g/ml. Protease inhibitors PMSF and
aprotinin were subsequently added to terminate the digestion.
(a) Virion particles after digestion overnight at room temperature were
sedimented through a 25% sucrose cushion, and the proteins in the
pellets were analyzed by western blotting with anti-HA, anti-capsid and
anti-p15E envelope antibodies. (b) Virion particles were subject to
subtilisin treatment in the presence of 0.2% NP-40, and then were
directly analyzed by western blotting with anti-HA and anti-capsid
antibodies.
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HA-enph 2
Env
Subtilisin
CA
HA-enph 2
Subtilisin
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Figure 6
Levels of endophilin 2 incorporation are saturable. A plasmid encoding
HA-endophilin 2 was cotransfected at a level of 0, 0.05, 0.1, 0.5, 1.0,
2.5, 5.0 or 10.0 g with 10 g of Mo-MuLV proviral DNA, pNCS. The
proteins in (a,c) viral particles and (b,d) cell lysates were analyzed by
western blotting with (a,b) anti-HA and (c,d) anti-capsid antibodies.
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production 
To evaluate the importance of endophilin 2 in virion pro-
duction, we examined virus yields in 293T cells depleted of
endophilin 2 by using synthetic small interfering (si) RNAs.
The 293T cells were transfected twice at 24 h intervals with
each of two pairs of synthetic siRNAs that were derived from
different regions of the endophilin 2 mRNA sequence.
During the second transfection, a Mo-MuLV proviral DNA
was cotransfected with the siRNAs. After an additional 24 h
post-transfection, culture medium was harvested and
virions were purified through a 25% sucrose cushion. Both
proteins in cell lysates and in viral particles were analyzed
by western blotting (Figure 8a). Endophilin 2 levels were
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Figure 7
Endogenous endophilin 2 and other endocytic proteins are incorporated into Mo-MuLV virions. The 293T cells were either mock-transfected or
transfected with a proviral DNA, pNCS. Equal amounts of cell lysates and virion particles were analyzed by western blotting with various antisera:
(a) anti-endophilin 2; (b) anti--adaptin (a subunit of AP-2); (c) anti-clathrin; (d) anti-dynamin 2. Two of these incorporated proteins were shown to
be protected from protease digestion within the virions after treatment with increasing levels of subtilisin: (e) -adaptin and (f) clathrin. Under these
conditions, the viral envelope protein is digested while the internal CA protein is protected.
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Subtilisinknocked down to about 20% of normal levels with siRNA1
(Figure 8a; lanes 1 and 4 compared to lane 3) or about 50%
with siRNA2 (Figure 8a; compare lanes 2 and 3); but we did
not observe any significant change of levels of virion-associ-
ated capsid. The reverse transcriptase activity of culture
medium displayed at most a two-fold reduction compared
to controls (Figure 8b). This experiment suggests that the
knock-down of endophilin 2 to these levels has no signifi-
cant effect on the course of viral production.
Inhibition of virion production by overexpression of
fragments of endophilin 2
If endophilins are important for virion production, the
overexpression of fragments or of wild-type endophilin 2
could exert dominant-negative effects on virion production.
A number of such constructs have been shown to affect
endocytosis [45-48]. N125 is a fragment of endophilin 2,
similar to the equivalent construct of endophilin 1, which
binds to lipsomes and tubulates them in vitro; N156 is a
fragment with a coiled-coil region; SH3 contains both
N125 and N156 regions but lacks the SH3 domain; V+SH3
contains both variable and SH3 domains and has previ-
ously been shown to interact with dynamin, synaptojanin
and amphiphysin [34,38,49]. These fragments were each
tagged with an influenza virus HA epitope at the amino ter-
minus. We first examined incorporation of these fragments
into virions with low expression in producer cells. We
cotransfected 293T cells transiently with a plasmid contain-
ing an individual HA-tagged fragment and a proviral DNA
at a 1:5 ratio. Culture supernatants were collected 48 h post-
transfection and virions were purified through a 25%/45%
sucrose step gradient. 
Analyzing proteins in cell lysates by western blotting
revealed that each fragment was expressed at substantial
levels, although some accumulated to higher levels than
others (Figure 9a; lanes 1-6). All four of the fragments were
incorporated into virions (Figure 9b; lanes 1-6). Serial dilu-
tions of the cell lysates were analyzed together with the
virion preparations on the same blots, to allow estimation
of the fraction of the intracellular proteins that were recov-
ered in the virions. To examine the potential role of the
amino terminus of endophilin 2 in incorporation, a mutant
lacking the first 33 amino acids (34) was also tested and
found to be equally well incorporated (data not shown). In
the case of the full-length HA-endophilin 2, as well as each
fragment, approximately 0.1-0.2% of the intracellular
protein was found in the virions. No single region of the
protein thus seemed to be essential for incorporation; the
fragments were incorporated even though they did not
show strong direct interaction with Gag in the yeast two-
hybrid assay system or in vitro. These results suggest that the
incorporation could be indirect, either through dimeriza-
tion with endogenous endophilin or interaction with other
cellular proteins that make direct contact with Gag. Alterna-
tively, there may be redundant contacts, or multiple regions
of endophilin that can mediate virion incorporation.
We proceeded to test the ability of these fragments to exert a
dominant-negative effect on virion production. To do so,
we cotransfected 293T cells transiently with a plasmid con-
taining an individual HA-tagged fragment and a proviral
DNA (pNCA) at a 5:1 ratio rather than at a 1:5 ratio. Con-
trols included for this experiment were: mock transfections;
cotransfection of proviral DNA with an empty expression
vector (Figure 10, lane 2); and cotransfection of a reporter
plasmid encoding a firefly luciferase to monitor for cytotox-
icity (Figure 10, lanes 2-7, and data not shown). Culture
medium was collected and virions were purified on a
25%/45% sucrose step gradient. The equivalent amounts of
cell lysate and virion released in culture medium were ana-
lyzed by western blotting. The fragments were readily
detected in transiently transfected cells (Figure 10a,
top panel; lanes 2-7). The overall level or stability of the
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Figure 8
Knock-down of endogenous endophilin 2 has no effect on viral
production. Synthetic siRNAs were transfected twice into 293T cells. A
Mo-MuLV proviral DNA pNCA was cotransfected with siRNAs at the
second transfection (see text). (a) Proteins in cell lysate and virion
particles were analyzed by western blotting with anti-endophilin 2 and
anti-capsid antibodies. (b) Virion production was monitored by assaying
reverse-transcriptase activity.
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(b)intracellular Gag precursor protein Pr65 was largely unaf-
fected by overexpression of endophilin 2 or its derivatives
or an empty vector control (Figure 10a, middle panel; lanes
2-7), indicating that there were no general cytotoxic effects
induced by overexpression of these fragments. Overexpres-
sion of full-length endophilin 2 dramatically decreased
(approximately 10-fold) the level of virion-associated Gag
and capsid detected in the culture medium (Figure 10a,
bottom panel; lane 6), as compared to that of the empty
vector transfected cells (Figure 10a, bottom panel; lane 2).
Overexpression of N125, SH3 or V+SH3 caused modest
reduction (around 2- to 3-fold) in the yield of both virion-
associated Gag precursors Pr65 and capsid (Figure 10a,
bottom panel; lanes 3, 5 and 7). In contrast, we observed
that overexpression of N156 at levels comparable to that of
the other fragments showed little inhibition of virion-asso-
ciated Gag and capsid production (Figure 10a, bottom
panel; lane 4).
To extend these observations, we cotransfected 293T cells
with Mo-MuLV proviral construct pNCS and full-length
endophilin at increasing DNA ratios (1:0, 1:1, 1:2.5 and 1:5;
Figure 10b). We found that endophilin overexpression
induced a clear dose-dependent inhibition of Mo-MuLV
virion production. At a 1:2.5 ratio, virion production was
inhibited 3- to 4-fold; at a 1:5 ratio, more than 10-fold inhi-
bition was observed (Figure 10b; lanes 4 and 5). 
We also tested the effect of overexpressing full-length
endophilin 2 or fragments of it on HIV-1 virion production.
The experiment was carried out the same way as for Mo-
MuLV, except an HIV-1 codon-optimized gag-pol DNA con-
struct (pCMVgagpolBNkan) was used to generate HIV-1
virus-like particles. Overexpression of full-length endophilin
or fragments of it had only a minor effect, if any, on HIV-1
pr55Gag-based virus-like particle production (Figure 10c).
The N125 fragment had the only reproducible effect, and
this was a marginal one. Taken together, these results suggest
that high-level overexpression of endophilin 2 can induce a
significant inhibition of virion production for Mo-MuLV, but
not for HIV Gag production in 293T cells. The almost com-
plete lack of effect on HIV-1 virion production suggests that
the overexpression of these proteins is not causing broad
metabolic toxicity or depletion of plasma membrane as the
mechanism of blocking Mo-MuLV virion production. 
Discussion
In the experiments described here, we have presented evi-
dence that endophilins interact with the matrix or MA
domain of the Mo-MuLV Gag protein and may contribute to
the process of virion production. We detected an interaction
between Mo-MuLV Gag and endophilin 2 in the yeast two-
hybrid system, and in vitro, and in vivo. The analogous interac-
tion was not detected for all retroviral Gags, but was seen for
Mo-MuLV and RSV Gags. Further tests showed that exoge-
nously expressed endophilin 2 is associated with virion parti-
cles, and is protected within the viral envelope. Several
fragments of endophilin 2 were also incorporated into
virions; these experiments did not identify any specific
domain of endophilin as essential for the process, and it is
possible that more than one domain can direct incorpora-
tion. The endophilin fragments may have been targeted to
virions by dimerization with endogenous endophilin, or by
indirect interactions with other proteins. About 0.1-0.2% of
the intracellular levels of endophilin were recovered in virus,
even for those fragments which bound poorly to Gag in yeast.
Titrating the levels of endophilin expression showed that the
binding sites for endophilins during virion formation are
limited and the level of incorporated protein is saturable.
These observations suggest that the presence of endophilins
within virion particles is not simply attributable to mass
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Figure 9
Incorporation of fragments of endophilin 2 into virions. The 293T cells
were cotransfected with 1 g of plasmid encoding HA-tagged
endophilin 2 fragments and 5 g of Mo-MuLV proviral DNA. Proteins
in (a) cell lysates and (b,c) virion particles were analyzed by western
blotting with (a,b) anti-HA and (c) anti-capsid antibodies.
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Figure 10 (see legend on the next page)
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12 345 67action, but that the incorporation might be mediated
through specific contacts, with only a limited number of
sites for Gag-endophilin association. It is not clear whether
the incorporation per se is involved in virion production.
If the interaction is crucial for virion production, we
thought it possible that overexpression of full-length or
fragments of endophilins might interfere with this process
by perturbing the correct stoichiometry of the interaction
between endophilin and Gag, or other proteins required
for this process. Consistent with this notion, overexpres-
sion of full-length endophilin 2 did act in a dominant-neg-
ative fashion to significantly reduce Mo-MuLV virion
production. The inhibition occurred in a dose-responsive
manner. Overexpression of endophilin 2 or N156, a frag-
ment that contains a coiled-coil region, had no effect on
the level of expression of Gag precursor or a reporter gene
within the cells. Moreover, overexpression of endophilin or
its fragments had no or little effect on the production of
HIV virus-like particles, correlating with our observation
that there is no direct interaction between HIV-1 pr55Gag
and endophilin. These data further support the notion
that the inhibition of Mo-MuLV virion production we
observed is not a nonspecific consequence of overexpres-
sion on cell viability or physiology. Rather, overexpression
could titrate out Mo-MuLV Gag or other interacting pro-
teins that are specifically required for Mo-MuLV and not
HIV production. 
We used the siRNA method to knock-down endogenous
endophilin 2. This technique has been successfully used to
document the requirement of TSG101 in virion assembly
[25]. In our case, however, the knock-down of endogenous
endophilin 2 had no significant effect on virion yield. One
possibility is that the levels of endophilins remaining inside
cells after knock-down are sufficient to execute the required
functions; indeed, the levels required for virion production
may be very low, as only a very small proportion of the
intracellular protein is incorporated. The other possibility is
that other endophilin family members could compensate
for the loss of expression. Indeed, this is very likely because
endophilin 1 is expressed in 293T cells (data not shown)
and we have shown that it can interact with Gag. It is not
clear if the various endophilin family members are fully
interchangeable for this or even host functions. We do
know that the sequence of the siRNA oligonucleotides used
in these experiments is specific to endophilin 2, and would
not be able to affect the levels of endophilin 1. We were
unable to identify a sequence of suitable length that was an
identical match between the two mRNAs.
Retrovirus budding is the topological reverse of endocyto-
sis [50], and membrane curvature changes dramatically
from the relatively planar plasma membranes during for-
mation of 100 nm virions. So far it has not been docu-
mented whether proteins that modify membrane curvature
contribute to retroviral budding. In this study, we have
shown that overexpression of N125, a fragment of
endophilin that binds liposomes and induces tubules of
diameter 20-100 nm [39], or of full-length endophilin, a
protein that presumably promotes both positive and nega-
tive membrane curvature changes during the formation of
endocytic vesicles [48,51], causes a significant reduction of
virion production. These observations raise the possibility
that our overexpression disrupts normal endophilin func-
tions, and that the binding of lipids and subsequent pro-
motion of changes in plasma membrane curvature could
be one of the functions normally exerted by endophilin to
assist Mo-MuLV virion formation. It is noteworthy that
clathrin, like Gag, was long thought to be sufficient to drive
membrane budding by itself. More recently it has become
evident that groups of proteins have to work together to
bend a biological membrane [52]. Endophilin is not the
only protein that can induce membrane curvature. At least
three other proteins (dynamin, amphiphysin and epsin)
that are involved in clathrin-medicated endocytosis can
independently trigger membrane tubulation in vitro [53-
55]. These proteins might function at multiple stages
during vesicle formation. Morphological analyses indicate
that endophilin A is required for clathrin-mediated synap-
tic vesicle endocytosis at multiple stages, including the fol-
lowing: the early stage of endocytosis, the formation of
shallow pits; late stages, with the formation of deeply
invaginated, elongated pits; and fission [45,46]. Proteins
such as endophilin, which can help generate membrane
curvature, might be involved in virion production at
several stages, from formation of slightly curved membrane
structures to stalk-like structures until viral fission. 
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Effects on the release of virion-associated capsid of overexpression of endophilin 2 and its fragments. Plasmid (5 g) encoding HA-tagged endophilin
2 fragments was transfected into 293T cells with either (a) 1 g of Mo-MuLV proviral DNA (pNCA) or (c) 1 g of HIV-1 codon-optimized gag-pol
DNA construct CMVgagpolBNkan. In (b), 293T cells were cotransfected with 1g of Mo-MuLV proviral DNA (pNCS) and endophilin 2 at ratios of
1:0, 1:1, 1:2.5 and 1:5. The total DNA for each transfection was normalized at an amount of 6 g by addition of empty vector plasmid. Equal
amounts of cell lysate and virion particles were analyzed by western blotting with anti-HA (top panels in a, b and c), anti-Mo-MuLV capsid (middle
and bottom panels in a and b) or anti-p24 antibodies (c, middle and bottom panels).Endophilin may act as part of a large complex, and may
associate with many other proteins. The SH3 domain of
endophilin has been shown to bind to the proline-rich
domain of dynamin [38], amphiphysin [34] and synapto-
janin, a phosphatidylinositol 5-phosphatase implicated in
synaptic-vesicle uncoating [49]. We found that AP-2 and
clathrin, but not dynamin 2, are significantly incorporated
into virion particles. The incorporation of any one of the
various proteins involved in vesicular trafficking may
depend on the behavior of the particular complex in which
it resides; one explanation for the lack of incorporation of
dynamin 2 is that it may interact with a distinct pool of
endophilins, one that does not interact with Gag. 
Among the proteins associated with Gag are several other
proteins that are implicated in retrovirus budding. Tsg101 is
known to interact with the PTAP motif of the L domain of
HIV-1 and many other retroviruses, and is required for effi-
cient virion release. Members of the Nedd4 family, involved
in endocytosis and recycling of membrane proteins, interact
with the PPPY motif of the L domain of many other retro-
viruses and play a similar role. Dominant-negative fragments
of Nedd4-like family members inhibit the release of viral
particles much as we have seen for endophilin [28,29]. These
observations suggest that a completely functioning vesicular
trafficking pathway is required for retroviruses budding
[50,56,57]. Interactions with vesicles may also be involved in
earlier stages of trafficking of genomic RNA, Env and Gag to
the cell surface [58]; possibly the binding of endophilins to
Gag can promote their association with endosomal vesicles. 
Very recently, HIV-1 Gag has been shown to associate with the
endocytic protein AIP-1/Alix through specific contacts with the
Gag p6 domain [59,60]; Alix is known to interact with
endophilins [61]. This observation, along with our results,
suggests that endophilin could be another component that
is hijacked by retroviruses to promote virion production. 
Materials and methods
Yeast two-hybrid system
Yeast reporter strains CTY10-5d and GGY::171 [62] were
generously provided by R. Sternglanz. The yeast expression
vector pSH2-1 [63] encodes an amino-terminal LexA DNA-
binding domain (LexADB); pGADNOT encodes a carboxy-
terminal Gal4 activation domain (Gal4AD) [64]. Plasmids
containing Mo-MuLV, RSV, HIV-1, SIV-1 and MPMV Gag
were described previously [40-42]. Plasmids 6 and 8 are
identical to 3 2355 and 5 1304, respectively, as
described previously [40]. DNAs encoding Mo-MuLV MA,
p12, p12-CA and CA were amplified from pNCA [65] by
PCR and cloned into plasmid pSH2-1 to generate yeast two-
hybrid plasmids.
Yeast two-hybrid library screen
BM5def Gag was cloned into pGBT9 DNA-binding domain
vector (Clontech, Palo Alto, USA) and used to screen a V13
T-lymphoma cDNA library [66]. 
Recombinant proteins
The full-length cDNA encoding human endophilin 2 was
obtained from Chi Wai So (University of Hong Kong) [67-
69]. DNA encoding human endophilin 2 residues 1-125
(N125), 1-306 (SH3) or full length (1-368) was cloned
into pGEX2TKPL, a derivative of pGEX-2TK (Pharmacia, Pis-
cataway, USA). GST-fusion proteins were produced in bacte-
ria cells as described previously [43]. 
Mammalian plasmid DNAs
Mo-MuLV was expressed either from plasmid pNCA [65] or
from pNCS, a derivative carrying an SV40 origin of
replication in the plasmid backbone. The plasmid pCMVgag-
polBNkan (provided by George Pavlakis) contains a Rev-
independent, codon-optimized HIV-1 Gag-Pol gene driven
by a cytomegalovirus (CMV) promoter. The plasmids encod-
ing hemagglutinin (HA)-tagged nuc212 or p11 were as
described [43]. DNA encoding human endophilin 2 residues
1-125 (N125), 125-306 (N156), 1-306 (SH3), 34-368
(34), 268-368 (V+SH3), or full-length 1-368 (enph 2) was
cloned into a pcDNA3.1 vector encoding an amino-terminal
HA-epitope tag. 
Transfection and siRNA 
Four 21-nucleotide single-strand RNAs with symmetric 2
nucleotide 3 (2-deoxy) thymidine overhangs were ordered
from Dharmacon (Lafayette, USA). The sequence of siRNA
1 is: sense, 5-CACGGUGUCCAAGAUCCGTT-3; antisense,
5-ACGGAUCUUGGACACCGUGTT-3. The sequence of
siRNA 2 is: sense, 5-GUUCGAGGAGUCCAAGGAGTT-3;
antisense, 5-CUCCUUGGACUCCUCGAACTT-3. These
single-strand RNAs were annealed to produce duplexes. 
The 293T cells were cultured in six-well plates in 2 ml of
DMEM medium with 10% FBS and transfected with siRNAs
at 40% confluence by lipofectamine 2000 (Invitrogen, Carls-
bad, USA). The transfection was carried out twice in a row
(one transfection per day). A final concentration of 50 nM
siRNA duplexes was used in each transfection experiment. 
Transfection, virion purification, western analyses,
and subtilisin treatment 
The 293T cells were transfected with viral DNAs using
calcium phosphate [70]. Cells were lysed and supernatants
were harvested 48 h post-transfection unless stated other-
wise in the text. Centrifugation of virion particles and subtil-
isin digestion of virions were performed as previously
described [43]. Briefly, 293T cells were transfected with
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expressing HA-endophilin. The culture medium harvested
from 293T cells 48 h post-transfection was filtered through
a 0.45 m filter and virions were purified on 25%/45%
sucrose step gradient, followed by a second purification by
sedimentation through a 25% sucrose cushion. For quantifi-
cation of exogenously expressed endophilin and of the
control protein HA-p11, in cytosolic and virion fractions,
serial dilutions of cytosolic cell lysates and viral particles
were prepared in SDS-PAGE sample buffer. Samples were
loaded on the same SDS-acrylamide gel for electrophoresis
and analyzed by western blotting with anti-HA antibody. To
estimate the fraction of the cytosolic protein present in the
virions, signal intensities in the lanes were compared and
the dilution in the cytosolic series with the correspondingly
closest signal to that seen in the virions was identified. The
proportion in the virions was then calculated from the dilu-
tion giving comparable signals.
For subtilisin treatment, purified virion pellets were resus-
pended in subtilisin buffer (40 mM Tris pH 8, 2 mM CaCl2)
and incubated with various amounts of subtilisin
(Boehringer Mannheim, Indianapolis, USA) for digestion
overnight at room temperature. Reactions were stopped by
adding PMSF and aprotinin to final concentrations of 2 mM
and 1 g/ml, respectively. Particles were then purified
through a 25% sucrose cushion. For subtilisin digestion in
the presence of detergent, NP-40 was added to a final con-
centration of 0.2%. 
Exogenous reverse transcriptase assay
Exogenous reverse transcriptase assays were performed as
described previously [43]. The amount of DNA synthesized
was quantitated by PhosphorImager analysis of the radioac-
tivity of the reverse-transcribed product. 
Antibodies 
Anti-mouse endophilin 2 polyclonal antibody was previ-
ously described [38]. We found it also cross-reacted with
both the endogenous and the exogenously expressed
human endophilin 2, but not with endophilin 1 (data not
shown). Anti-dynamin 2 polyclonal antibody was from
Santa Cruz Biotech (Santa Cruz, USA). Anti-HA monoclonal
antibody was purchased from BabCO (Berkeley, USA). Anti-
clathrin and AP-2 monoclonal antibodies were from
Pharmingen (San Diego, USA). Goat polyclonal anti-CA
antiserum (79S-804) was obtained from the National
Cancer Institute (Bethesda, USA). 
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